Propelled by increasing prevalence of cardiovascular diseases The tissue plasminogen activator (tPA) market involves drugs administered intravenously or through catheter-directed administration to treat pulmonary embolism and ischemic stroke. tPA drugs work by dissolving blood clots and restoring blood flow. The growing global burden of cardiovascular diseases such as heart attacks, strokes, and pulmonary embolism has led to a rise in demand for effective...
0 Shares
522 Views
0 Reviews